We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congress Seeks GAO Review of Foreign Drug Inspection Program
Congress Seeks GAO Review of Foreign Drug Inspection Program
Ongoing recalls of contaminated blood pressure drugs prompted the House Energy and Commerce Committee to call on Friday for a review of the FDA’s foreign drug inspection program.